Canadian CANNAINVESTOR Magazine May / June 2018 | Page 237

237

3 R&D for clinical trials.

3 Domestic production for export (note: there will be a partial offset from imports). If you believe those that claim this is an insignificant amount then time to reassess why you read their reports. LINK TO THE SOURCE FOR IMAGE BELOW.

3 Natural market growth as public education and acceptance grows and as the black-market supply and distribution continues to diminish. Please see point #4 for third party analysis that predicts and depicts the erosion of the black market.

3 The medical grade component to this industry will also increase in demand.

3 The natural reduction in costs from seed to sale will also place downward pressure on price and as price falls demand increases. Remember, keep it simple – it is about supply and demand.

Reflect on the above as you read this month’s “From The Retail Investor’s perspective”. The 27 pages of doom and gloom written on Isodiol by short sellers followed up by another doozy on Namaste could have been shortened to just a page or two and factual based rather than filled with conjecture, opinion, and speculation. Both companies have been acquiring and investing predominantly through the issuance of shares. Supply and demand explains it all. Increase the supply significantly and the price falls. In time, the market absorbs these shares and a new true tend will follow. Do not overthink it.